13F Holdings
中文EN

FOFA FAMILY OFFICE OF AMERICA, INC.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1871181 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY47.9%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-13.4%
ROA-7.4%
ROIC (approx.)-44.8%
Asset turnover—

Leverage & solvency

Liabilities / assets59.1%
Debt / equity0.00x
Current ratio0.75x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-1.93x
Accruals ratio-21.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$221,765————
Gross profit$221,765————
R&D expense——$1,500$76,360$500,567
SG&A expense$516,362$96,513$152,630$596,232$922,182
Operating income-$501,079-$96,513-$230,241-$920,515-$1.59M
Pretax income-$492,748-$100,484-$805,021-$920,515-$1.73M
Net income-$492,748-$100,484-$805,021-$920,515-$1.73M
EBITDA——-$212,991-$903,413-$1.57M
EPS (basic)-0.020.00-0.09-0.11-0.25
EPS (diluted)-0.020.00-0.09-0.11—
Weighted avg. shares (diluted)26.68M20.26M8.48M8.33M6.93M
Banking
Net interest income-$5,678-$3,971———
Balance sheet
Cash & equivalents$155,798$13,586$2,431$69,858$528,284
Receivables$74,764————
Inventory———$40,175$60,275
Current assets$270,359$20,581$2,431$256,203$743,703
PP&E, net———$39,258$56,360
Goodwill$835,600————
Intangibles$437,083————
Total assets$1.54M$20,581$2,431$295,461$800,063
Current liabilities$578,533$44,021$525,387$71,507$29,648
Long-term debt$300,000————
Total debt$300,000————
Total liabilities$878,533$44,021$525,387$71,507$29,648
Shareholders' equity$664,509-$23,440-$522,956$223,954$770,415
Net debt$144,202————
Shares outstanding30.20M20.44M8.44M8.48M8.24M
Cash flow statement
Operating cash flow-$262,188-$89,370-$76,529-$558,426-$792,844
Capital expenditure————$1,787
Free cash flow————-$794,631
Investing cash flow-$560,600———-$1,787
Financing cash flow$965,000$100,525$9,102$100,000$1.25M
Depreciation & amortization——$17,250$17,102$16,953
Stock-based compensation$137,309—$45,763-$94,101$166,141

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.